Aug 7 (Reuters) - Bausch Health Companies Inc BHC.TO :
* BAUSCH HEALTH COMPANIES INC. ANNOUNCES SECOND-QUARTER 2018 RESULTS
* QTRLY REVENUES OF $2.128 BILLION
* MAINTAINED REVENUE GUIDANCE RANGE AND RAISED FULL-YEAR ADJUSTED EBITDA (NON-GAAP) GUIDANCE RANGE
* Q2 GAAP LOSS PER SHARE C$2.49
* BAUSCH HEALTH COMPANIES - ADJUSTED NET INCOME (NON-GAAP) FOR Q2 WAS $327 MILLION VERSUS $362 MILLION
* SEES FULL-YEAR ADJUSTED EBITDA (NON-GAAP) IN RANGE OF $3.20 BILLION TO $3.35 BILLION FROM $3.15 BILLION TO $3.30 BILLION
* BAUSCH HEALTH - IN QUARTER, ORGANIC REVENUE GROWTH WAS PARTIALLY OFFSET BY DECLINES IN ORTHO DERMATOLOGICS SEGMENT, LOWER VOLUMES IN DIVERSIFIED PRODUCTS SEGMENT
* Q2 REVENUE VIEW $2.06 BILLION -- THOMSON REUTERS I/B/E/S